ES2396730T3 - Anticuerpos monoclonales anti-anexina A3 para la detección de carcinoma de próstata - Google Patents

Anticuerpos monoclonales anti-anexina A3 para la detección de carcinoma de próstata Download PDF

Info

Publication number
ES2396730T3
ES2396730T3 ES07725949T ES07725949T ES2396730T3 ES 2396730 T3 ES2396730 T3 ES 2396730T3 ES 07725949 T ES07725949 T ES 07725949T ES 07725949 T ES07725949 T ES 07725949T ES 2396730 T3 ES2396730 T3 ES 2396730T3
Authority
ES
Spain
Prior art keywords
antibody
annexin
anxa3
prostate cancer
essentially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07725949T
Other languages
English (en)
Spanish (es)
Inventor
André SCHRATTENHOLZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProteoSys AG
Original Assignee
ProteoSys AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProteoSys AG filed Critical ProteoSys AG
Application granted granted Critical
Publication of ES2396730T3 publication Critical patent/ES2396730T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES07725949T 2006-06-09 2007-06-11 Anticuerpos monoclonales anti-anexina A3 para la detección de carcinoma de próstata Active ES2396730T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US812089P 2006-06-09
US85948906P 2006-11-17 2006-11-17
US859489P 2006-11-17
PCT/EP2007/005134 WO2007141043A2 (en) 2006-06-09 2007-06-11 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma

Publications (1)

Publication Number Publication Date
ES2396730T3 true ES2396730T3 (es) 2013-02-25

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07725949T Active ES2396730T3 (es) 2006-06-09 2007-06-11 Anticuerpos monoclonales anti-anexina A3 para la detección de carcinoma de próstata

Country Status (13)

Country Link
US (1) US8012697B2 (https=)
EP (1) EP2024748B1 (https=)
JP (1) JP2009540278A (https=)
KR (1) KR20090023372A (https=)
AU (1) AU2007256377B2 (https=)
CA (1) CA2654330A1 (https=)
DE (1) DE07725949T1 (https=)
DK (1) DK2024748T3 (https=)
ES (1) ES2396730T3 (https=)
PL (1) PL2024748T3 (https=)
PT (1) PT2024748E (https=)
RU (1) RU2467335C2 (https=)
WO (1) WO2007141043A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
EP2344544A2 (en) * 2008-09-26 2011-07-20 ProteoSys AG Novel antibodies recognizing native annexin a3
FR2968767B1 (fr) 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
WO2015035941A1 (en) * 2013-09-12 2015-03-19 The University Of Hong Kong Use of annexin a3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
JP5068543B2 (ja) * 2004-02-16 2012-11-07 プロテオジス アクチェンゲゼルシャフト がんに関する診断マーカー
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment

Also Published As

Publication number Publication date
US8012697B2 (en) 2011-09-06
EP2024748A2 (en) 2009-02-18
KR20090023372A (ko) 2009-03-04
AU2007256377B2 (en) 2012-11-01
WO2007141043A2 (en) 2007-12-13
RU2008152009A (ru) 2010-07-20
AU2007256377A1 (en) 2007-12-13
CA2654330A1 (en) 2007-12-13
JP2009540278A (ja) 2009-11-19
RU2467335C2 (ru) 2012-11-20
DE07725949T1 (de) 2009-07-02
EP2024748B1 (en) 2012-12-12
DK2024748T3 (da) 2013-03-18
WO2007141043A3 (en) 2008-03-20
PL2024748T3 (pl) 2013-05-31
PT2024748E (pt) 2013-01-16
US20100233160A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
ES2396730T3 (es) Anticuerpos monoclonales anti-anexina A3 para la detección de carcinoma de próstata
Katayama et al. Soluble E-cadherin fragments increased in circulation of cancer patients
JP4813661B2 (ja) 癌を診断するための方法および組成物
ES2748397T3 (es) Uso de HE4 y otros marcadores bioquímicos para la evaluación de cánceres de ovario
ES2588194T3 (es) Detección y tratamiento de cáncer pancreático, de ovario y otros cánceres
JP5797136B2 (ja) 癌腫の診断
ES2992753T3 (en) Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis
JP5468587B2 (ja) Ｃｄ４４の表面発現を証明する細胞の細胞毒性媒介
US6770445B1 (en) Methods and compositions for diagnosing carcinomas
Rochaix et al. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen
JP2019501901A (ja) 炎症性腸疾患の治療及び診断のための抗体
He et al. Preclinical evaluation of a fluorescent probe targeting receptor CDCP1 for identification of ovarian cancer
ES2411921T3 (es) Uso de HE4 para la evaluación de cánceres de mama
KR20120095301A (ko) 항-사이토케라틴 8/18 복합체 자가면역항체를 포함하는 암 진단 마커 및 이의 항원을 포함하는 암 진단용 조성물
KR20170029414A (ko) 암을 스크리닝하고 검출하는 방법 및 조성물
Jeschke et al. Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors
US20110177536A1 (en) Novel antibodies recognizing native annexin a3
ES2219108T3 (es) Sustancia para producir medicamentos antitumorales altamente eficaces y su metodo correspondiente.
US20100166652A1 (en) Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody
CN101501501A (zh) 用于检测前列腺癌的抗膜联蛋白a3单克隆抗体
ES2274220T3 (es) Diagnostico de carcinoma usando polipeptidos raig1.
Kawata et al. Detection of epithelial ovarian-cancer-associated antigens involved in immune complexes by monoclonal antibodies
Roos et al. ¡ OS9 TUMOR MARKER EVALUATION (PART 3) _
JP2008540624A (ja) 癌の処置／診断のためのｐｓｋ−１及びそのモジュレーター